WBB Securities Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: WBB Securities
Rating: 2.7
Author: MarketBeat

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at WBB Securities. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by WBB Securities.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
CDTX Cidara Therapeutics	$0.73 +0.7%	9/22/2021	Upgraded by	WBB Securities	-	Buy -> Strong-Buy	$6.25	High	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/22/2021
OMER Omeros	$3.35 +0.3%	6/18/2021	Target Raised by	WBB Securities	-	Strong-Buy	$75.00 -> $100.00	Medium	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/18/2021
RDHL RedHill Biopharma	$0.41 +5.9%	5/28/2021	Downgraded by	WBB Securities	-	Strong-Buy -> Buy	$680.00 -> $640.00	High	View details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 5/28/2021
ARCT Arcturus Therapeutics	$27.02 -2.2%	6/9/2020	Downgraded by	WBB Securities	-	Buy -> Hold	$31.00	Low	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/9/2020
CDTX Cidara Therapeutics	$0.73 +0.7%	12/4/2019	Upgraded by	WBB Securities	-	Speculative Buy -> Buy	$6.25	Medium	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 12/4/2019
RDHL RedHill Biopharma	$0.41 +5.9%	7/12/2019	Upgraded by	WBB Securities	-	Buy -> Strong-Buy	$680.00	High	View details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 7/12/2019
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ADMA ADMA Biologics	$6.04	4/4/2019	Upgraded by	WBB Securities	-	Buy		Low	View details for WBB Securities rating of ADMA Biologics (NASDAQ:ADMA) on 4/4/2019
MRKR Marker Therapeutics	$4.24 -1.6%	3/29/2019	Upgraded by	WBB Securities	-	Buy -> Strong-Buy	$7.29	High	View details for WBB Securities rating of Marker Therapeutics (NASDAQ:MRKR) on 3/29/2019
RDHL RedHill Biopharma	$0.41 +5.9%	3/12/2019	Upgraded by	WBB Securities	-	Speculative Buy -> Buy	$680.00	High	View details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 3/12/2019
RDHL RedHill Biopharma	$0.41 +5.9%	12/31/2018	Initiated by	WBB Securities	-	Buy	$214.40	Medium	View details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 12/31/2018
ARCT Arcturus Therapeutics	$27.02 -2.2%	9/20/2018	Upgraded by	WBB Securities	-	Buy -> Strong-Buy		Low	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/20/2018
SRPT Sarepta Therapeutics	$115.91 -1.7%	6/20/2018	Reiterated by	WBB Securities	-	Buy		Low	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/20/2018
ARCT Arcturus Therapeutics	$27.02 -2.2%	6/11/2018	Upgraded by	WBB Securities	-	Hold -> Buy		Medium	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/11/2018
CDTX Cidara Therapeutics	$0.73 +0.7%	5/23/2018	Upgraded by	WBB Securities	-	Hold -> Buy		Medium	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 5/23/2018
OMER Omeros	$3.35 +0.3%	3/26/2018	Reiterated by	WBB Securities	-	Buy	$75.00	High	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/26/2018
CLDX Celldex Therapeutics	$39.25 -1.0%	12/6/2017	Reiterated by	WBB Securities	-	Buy	$150.00	Low	View details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 12/6/2017
ARCT Arcturus Therapeutics	$27.02 -2.2%	10/9/2017	Upgraded by	WBB Securities	-	Hold -> Buy	$2.00	N/A	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 10/9/2017
LIVN LivaNova	$52.35 +0.9%	8/15/2017	Downgraded by	WBB Securities	-	Hold -> Sell	$50.00	Low	View details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/15/2017
CDTX Cidara Therapeutics	$0.73 +0.7%	8/11/2017	Upgraded by	WBB Securities	-	Sell -> Hold		Low	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 8/11/2017
OMER Omeros	$3.35 +0.3%	6/14/2017	Reiterated by	WBB Securities	-	Strong-Buy	$75.00	High	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2017
OMER Omeros	$3.35 +0.3%	3/30/2017	Reiterated by	WBB Securities	-	Buy	$75.00	Medium	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/30/2017
CDTX Cidara Therapeutics	$0.73 +0.7%	2/22/2017	Upgraded by	WBB Securities	-	Sell -> Hold	$7.25	N/A	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 2/22/2017
TTOO T2 Biosystems	$2.93 -0.3%	2/5/2017	Reiterated by	WBB Securities	-	Buy	$60,000.00	N/A	View details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 2/5/2017
OMER Omeros	$3.35 +0.3%	11/17/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$75.00	N/A	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 11/17/2016
ARCT Arcturus Therapeutics	$27.02 -2.2%	11/2/2016	Upgraded by	WBB Securities	-	Sell -> Hold	$4.00 -> $1.90	N/A	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/2/2016
OMER Omeros	$3.35 +0.3%	10/17/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$75.00	N/A	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 10/17/2016
SCYX SCYNEXIS	$1.44 +1.4%	10/7/2016	Upgraded by	WBB Securities	-	Buy -> Strong-Buy	$80.00	N/A	View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 10/7/2016
CDTX Cidara Therapeutics	$0.73 +0.7%	9/23/2016	Downgraded by	WBB Securities	-	Hold -> Sell	$10.50	N/A	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/23/2016
SRPT Sarepta Therapeutics	$115.91 -1.7%	9/20/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Strong-Buy	$40.00 -> $60.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/20/2016
ARCT Arcturus Therapeutics	$27.02 -2.2%	9/12/2016	Downgraded by	WBB Securities	-	Hold -> Sell	$5.00 -> $4.00	N/A	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/12/2016
LIVN LivaNova	$52.35 +0.9%	8/31/2016	Reiterated by	WBB Securities	-	Hold	$60.00	N/A	View details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/31/2016
SCYX SCYNEXIS	$1.44 +1.4%	8/9/2016	Upgraded by	WBB Securities	-	Speculative Buy -> Buy	$80.00	N/A	View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 8/9/2016
TTOO T2 Biosystems	$2.93 -0.3%	7/20/2016	Upgraded by	WBB Securities	Analyst Stephen Brozak	Buy -> Strong-Buy	$55,000.00 -> $60,000.00	N/A	View details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 7/20/2016
TTOO T2 Biosystems	$2.93 -0.3%	7/8/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$55,000.00	N/A	View details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 7/8/2016
TTOO T2 Biosystems	$2.93 -0.3%	6/22/2016	Upgraded by	WBB Securities	Analyst Stephen Brozak	Speculative Buy -> Buy	$55,000.00	N/A	View details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 6/22/2016
OMER Omeros	$3.35 +0.3%	6/14/2016	Reiterated by	WBB Securities	-	Buy	$75.00	N/A	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2016
SRPT Sarepta Therapeutics	$115.91 -1.7%	6/8/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$40.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/8/2016
SRPT Sarepta Therapeutics	$115.91 -1.7%	5/2/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Strong-Buy	$40.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2016
SRPT Sarepta Therapeutics	$115.91 -1.7%	4/26/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$40.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/26/2016
SRPT Sarepta Therapeutics	$115.91 -1.7%	3/30/2016	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$40.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/30/2016
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide
TTOO T2 Biosystems	$2.93 -0.3%	2/17/2016	Initiated by	WBB Securities	-	Speculative Buy	$55,000.00	N/A	View details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 2/17/2016
TZOO Travelzoo	$8.92 +0.9%	2/17/2016	Initiated by	WBB Securities	-	Speculative Buy	$11.00	N/A	View details for WBB Securities rating of Travelzoo (NASDAQ:TZOO) on 2/17/2016
SCYX SCYNEXIS	$1.44 +1.4%	1/4/2016	Initiated by	WBB Securities	Analyst Stephen Brozak	Buy	$80.00	N/A	View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 1/4/2016
SCYX SCYNEXIS	$1.44 +1.4%	12/29/2015	Initiated by	WBB Securities	-	Buy	$80.00	N/A	View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 12/29/2015
SRPT Sarepta Therapeutics	$115.91 -1.7%	11/22/2015	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$40.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/22/2015
CTSO Cytosorbents	$0.81 +2.5%	10/29/2015	Upgraded by	WBB Securities	-	Speculative Buy -> Buy	$13.00	N/A	View details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 10/29/2015
CDTX Cidara Therapeutics	$0.73 +0.7%	10/9/2015	Upgraded by	WBB Securities	-	Sell -> Hold	$13.00	N/A	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 10/9/2015
OMER Omeros	$3.35 +0.3%	8/18/2015	Target Raised by	WBB Securities	-	Strong-Buy	$60.00 -> $75.00	N/A	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015
OMER Omeros	$3.35 +0.3%	8/18/2015	Reiterated by	WBB Securities	-	Buy	$60.00	N/A	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015
SRPT Sarepta Therapeutics	$115.91 -1.7%	8/13/2015	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$35.00 -> $40.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/13/2015
ARCT Arcturus Therapeutics	$27.02 -2.2%	8/9/2015	Reiterated by	WBB Securities	-	Hold	$5.00	N/A	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 8/9/2015
ARCT Arcturus Therapeutics	$27.02 -2.2%	6/24/2015	Downgraded by	WBB Securities	-	Speculative Buy -> Hold	$5.00	N/A	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/24/2015
CLDX Celldex Therapeutics	$39.25 -1.0%	6/1/2015	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy	$450.00 -> $600.00	N/A	View details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 6/1/2015
SRPT Sarepta Therapeutics	$115.91 -1.7%	5/22/2015	Reiterated by	WBB Securities	Analyst Stephen Brozak	Strong-Buy	$25.00 -> $35.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/22/2015
CDTX Cidara Therapeutics	$0.73 +0.7%	4/23/2015	Initiated by	WBB Securities	-	Sell	$13.00	N/A	View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2015
CTSO Cytosorbents	$0.81 +2.5%	2/25/2015	Initiated by	WBB Securities	-	Speculative Buy	$13.00	N/A	View details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2015
SRPT Sarepta Therapeutics	$115.91 -1.7%	1/15/2015	Reiterated by	WBB Securities	Analyst Stephen Brozak	Buy		N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/15/2015
SRPT Sarepta Therapeutics	$115.91 -1.7%	11/26/2014	Upgraded by	WBB Securities	Analyst Stephen Brozak	Buy -> Strong-Buy	$25.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2014
SRPT Sarepta Therapeutics	$115.91 -1.7%	7/29/2014	Upgraded by	WBB Securities	Analyst Stephen Brozak	Speculative Buy -> Buy		N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014
SRPT Sarepta Therapeutics	$115.91 -1.7%	7/29/2014	Target Raised by	WBB Securities	Analyst Stephen Brozak	Speculative Buy -> Buy	$25.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014
ARCT Arcturus Therapeutics	$27.02 -2.2%	6/26/2014	Initiated by	WBB Securities	-	Hold	$18.00	N/A	View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/26/2014
OMER Omeros	$3.35 +0.3%	4/7/2014	Target Raised by	WBB Securities	-	Strong-Buy	$20.00 -> $30.00	N/A	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 4/7/2014
SRPT Sarepta Therapeutics	$115.91 -1.7%	11/26/2013	Upgraded by	WBB Securities	-	Sell -> Speculative Buy	$9.00 -> $19.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2013
PATH UiPath	$19.14 +0.1%	1/22/2013	Upgraded by	WBB Securities	-	Buy -> Strong-Buy	$7.00	N/A	View details for WBB Securities rating of UiPath (NYSE:PATH) on 1/22/2013
SSKN STRATA Skin Sciences	$0.49 -7.2%	9/24/2012	Upgraded by	WBB Securities	-	Hold -> Speculative Buy	$20.00 -> $40.00	N/A	View details for WBB Securities rating of STRATA Skin Sciences (NASDAQ:SSKN) on 9/24/2012
SRPT Sarepta Therapeutics	$115.91 -1.7%	9/12/2012	Downgraded by	WBB Securities	-	Hold -> Sell	$8.00 -> $9.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/12/2012
BCRX BioCryst Pharmaceuticals	$4.63 +1.1%	8/14/2012	Downgraded by	WBB Securities	-	Buy -> Hold	$8.50 -> $4.40	N/A	View details for WBB Securities rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 8/14/2012
SRPT Sarepta Therapeutics	$115.91 -1.7%	8/9/2012	Initiated by	WBB Securities	-	Buy -> Hold	$8.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/9/2012
VCEL Vericel	$44.26 -4.3%	7/24/2012	Upgraded by	WBB Securities	-	Buy -> Strong-Buy	$3.00 -> $3.00	N/A	View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 7/24/2012
VCEL Vericel	$44.26 -4.3%	6/4/2012	Upgraded by	WBB Securities	-	Speculative Buy -> Buy	$3.00	N/A	View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 6/4/2012
VCEL Vericel	$44.26 -4.3%	4/16/2012	Upgraded by	WBB Securities	-	Hold -> Speculative Buy	$2.50 -> $3.00	N/A	View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 4/16/2012
OMER Omeros	$3.35 +0.3%	3/22/2012	Target Raised by	WBB Securities	-	Strong-Buy	$10.50 -> $20.00	N/A	View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/22/2012
JAZZ Jazz Pharmaceuticals	$108.31 +1.1%	12/8/2011	Downgraded by	WBB Securities	-	Buy -> Hold	$15.00 -> $40.00	N/A	View details for WBB Securities rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 12/8/2011
VCEL Vericel	$44.26 -4.3%	12/6/2011	Upgraded by	WBB Securities	-	Sell -> Hold	$2.00 -> $2.50	N/A	View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 12/6/2011
GERN Geron	$3.80 +3.3%	11/16/2011	Downgraded by	WBB Securities	-	Strong Buy -> Buy	$19.00 -> $6.00	N/A	View details for WBB Securities rating of Geron (NASDAQ:GERN) on 11/16/2011
MBOT Microbot Medical	$0.86 -4.2%	7/7/2011	Initiated by	WBB Securities	-	Sell	$36.00	N/A	View details for WBB Securities rating of Microbot Medical (NASDAQ:MBOT) on 7/7/2011
EBS Emergent BioSolutions	$1.96 +2.9%	5/31/2011	Target Raised by	WBB Securities	-	Strong Buy	$20.50 -> $30.00	N/A	View details for WBB Securities rating of Emergent BioSolutions (NYSE:EBS) on 5/31/2011
PLX Protalix BioTherapeutics	$1.14 -0.9%	3/17/2011	Downgraded by	WBB Securities	-	Strong-Buy -> Buy	$100.00	N/A	View details for WBB Securities rating of Protalix BioTherapeutics (NYSE:PLX) on 3/17/2011
VCEL Vericel	$44.26 -4.3%	2/9/2011	Initiated by	WBB Securities	-	Sell	$2.00	N/A	View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 2/9/2011
OSIR Osiris Therapeutics	$18.99	1/31/2011	Downgraded by	WBB Securities	-	Sell -> Sell Short	$5.00 -> $5.00	N/A	View details for WBB Securities rating of Osiris Therapeutics (OTCMKTS:OSIR) on 1/31/2011
SRPT Sarepta Therapeutics	$115.91 -1.7%	12/29/2010	Initiated by	WBB Securities	-	Speculative Buy	$3.00	N/A	View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/29/2010

MarketBeat Community Rating for WBB Securities

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		24,019 (Vote Outperform)
Underperform Votes:		20,742 (Vote Underperform)
Total Votes:		44,761

MarketBeat's community ratings are surveys of what our community members think about WBB Securities and other research firms. Vote "Outperform" if you believe WBB Securities's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WBB Securities's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

WBB Securities Analyst Recommendations & Stock Picks

MarketBeat Community Rating for WBB Securities

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info